跳至主要内容
临床试验/NCT05244694
NCT05244694已完成早期 1 期

Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction

University of Missouri-Columbia1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2020年8月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
28
试验地点
1
主要终点
Amount of leg blood flow

研究概览

简要总结

The purpose of this project is to determine if hyperinsulinemia attenuates sympathetic nervous system-mediated vasoconstriction in the human leg.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • healthy adult men and women;
  • 18-45 years of age;
  • BMI 18-30 kg/m2;
  • non-pregnant/non-breastfeeding;
  • non-nicotine users;

排除标准

  • taking any medications known to affect metabolic, respiratory, cardiovascular, and/or autonomic functions
  • Self-reported history of:
  • hepatic, renal, pulmonary, cardiovascular, or neurological disease;
  • stroke or neurovascular disease;
  • bleeding/clotting disorders;
  • sleep apnea or other sleep disorders;
  • diabetes;
  • history of alcoholism or substance abuse, excessive alcohol consumption;
  • hypertension;
  • active cancer;
  • autoimmune disease;
  • immunosuppressant therapy

研究组 & 干预措施

Insulin

Experimental

Participants will complete a 60 minute hyperinsulinemic-euglycemic infusion.

干预措施: Insulin (Drug)

结局指标

主要结局

Amount of leg blood flow

时间窗: Change from baseline at minute 60

Measured with Doppler ultrasound (mL/min)

次要结局

  • Amount of cerebral blood flow(Change from baseline at minute 60)
  • Amount of muscle sympathetic nerve activity (MSNA)(Change from baseline at minute 60)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jacqueline K Limberg, PhD

Assistant Professor

University of Missouri-Columbia

研究点 (1)

Loading locations...

相似试验